NaseemaGangatMD

Instructor, Internal Medicine, Mayo Medical School

Dr. Gangat is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2007 - 2010
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2004 - 2007
Aga Khan Medical CollegeClass of 2002

Actuate 1901: 9-ING-41 in Myelofibrosis Start of enrollment: 2020 Aug 20
Completed
Phase 2
Roles: Contact

PubMed

995 citations
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Daniel A Arber, Attilio Orazi, Robert P Hasserjian, Michael J Borowitz, Katherine R Calvo
Blood. 2022-09-15
5 citations
CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes.
Evandro D. Bezerra, Terra L. Lasho, Christy Finke, Antoine N. Saliba, Michelle A. Elliott
Blood Cancer Journal. 2021-03-11
202 citations
GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis
Ayalew Tefferi, Paola Guglielmelli, Maura Nicolosi, Francesco Mannelli, Mythri Mudireddy
Leukemia. 2018-03-23

Journal Articles

MPL-Mutated Essential Thrombocythemia: A Morphologic Reappraisal
Naseema Gangat, Natasha Szuber, Rhett P Ketterling, Nature
Determinants of Long-Term Outcome in Type 1 Calreticulin-Mutated Myelofibrosis
Naseema Gangat, Natasha Szuber, Rhett P Ketterling, Nature